Form D · Other Health Care

Ostentus Therapeutics, Inc.

Newport Coast, CA · CIK 0001901024

Offering snapshot reported Mar 8, 2024 · SEC filing

Reported sold
$150K
Offering amount: $9.8M
Investors reported
2
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Feb 24, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 8, 2024Initial$150,000No comparison2SEC filing
Oct 13, 2022Initial$520,000No comparison7SEC filing
Oct 6, 2022Initial$487,500No comparison4SEC filing
Jan 26, 2022Initial$100,000No comparison1SEC filing
Dec 23, 2021Initial$500,000No comparison5SEC filing

Offering details

Securities
Equity
Exemptions
06c
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-507024

Source: Form D, filed Mar 8, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Elisabetta Graff Director, Executive, Promoter
William Graff Director, Promoter
Stuart Weinstein Director, Promoter

Issuer details

Industry: Other Health Care (See others in industry)

Address:
12 Gentle Breeze
Newport Coast, CA, 92657